WO2009086934A1 - Composition for treating scalp and skin - Google Patents

Composition for treating scalp and skin Download PDF

Info

Publication number
WO2009086934A1
WO2009086934A1 PCT/EP2008/050237 EP2008050237W WO2009086934A1 WO 2009086934 A1 WO2009086934 A1 WO 2009086934A1 EP 2008050237 W EP2008050237 W EP 2008050237W WO 2009086934 A1 WO2009086934 A1 WO 2009086934A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition according
composition
eggs
calcium
acetic acid
Prior art date
Application number
PCT/EP2008/050237
Other languages
French (fr)
Inventor
Anne-Marie Deroche
Original Assignee
Anne-Marie Deroche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anne-Marie Deroche filed Critical Anne-Marie Deroche
Priority to PCT/EP2008/050237 priority Critical patent/WO2009086934A1/en
Publication of WO2009086934A1 publication Critical patent/WO2009086934A1/en
Priority to IL206695A priority patent/IL206695A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23Sulfur; Selenium; Tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24Phosphorous; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Definitions

  • the present invention belongs to the field of formulations intended for topical application for therapeutic or non-therapeutic purposes, prepared by extraction of useful compounds from naturally occurring materials.
  • composition based on proteins, calcium, minerals and oligomers in solution in dilute acetic acid, and a process for preparing from ingredients of exclusively natural origin.
  • a product comprising said composition, intended for the therapeutic or cosmetic treatment of the skin and the scalp, is also claimed.
  • Protein, calcium, mineral salts and trace elements are naturally present in our body and are essential for its proper functioning. Calcium is a key player. It is found involved in multiple metabolic actions involved in particular in the construction of the structure of the skin.
  • the reproductive cells of the hair follicles are normally programmed to regenerate and give birth to new hair in an uninterrupted way thanks to cycles of growth set between 25 to 30 cycles, which have a duration of 2 to 5 years, are sufficient in number to renew the hair for a lifetime.
  • the hormonal receptors of these target organs become particularly sensitive to the harmful action of dihydrotestosterone resulting from testosterone under the effect of 5- ⁇ -reductase.
  • Slowing down the rate of cell divisions and the deterioration of the functioning of the hair follicles results in a decrease in growth cycles that quickly run out, from a few years to a few months. The hair clears and, if we do not stop the fall, we see the final loss of hair.
  • the study of the composition of the eggshell shows that it contains on average 3.3% of proteins constituting its frame. These proteins play a major role in the processes of calcification of the shell by crystallizing about 95.1% of minerals, mainly calcium carbonate crystals in the form of calcite. The proteins and calcium absorbed within the organic matrix are therefore very closely involved in the construction of the crystalline microstructure of the shell, which contributes to its strength.
  • the composition according to the present invention makes it possible to reproduce, at the level of the structures of the skin, the mechanisms of natural solidity resulting from the affinity of proteins and calcium in the constitution of the shell.
  • the composition according to the invention brings to the heart damaged or broken cells, all the nutrients necessary for the restoration of functioning. cellular. By restoring the calcium metabolism, the claimed composition reinforces the cohesion of the cutaneous tissues and helps to fight against skin aging.
  • the subject of the present invention is a composition intended for the preparation of a product for therapeutic or cosmetic use, containing, in soluble form in aqueous phase:
  • composition according to the invention comprises the listed mineral salts with the following respective contents: sodium: 1, 70% to 2.50%
  • composition according to the invention comprises the trace elements listed with the respective contents as follows:
  • the protein / calcium ratio is in the range from 0.8 to 0.9.
  • the proteins and calcium comprise the solubilized forms of compounds naturally occurring in the poultry eggshell.
  • the composition is characterized in that it contains from 0.40% to 0.45% of proteins originating from essentially eggshell and 0.50% to 0.51% calcium from eggshell calcite dissolved in water with 4.70% acetic acid. This state of affairs makes it possible to further underline the natural origin of the composition claimed.
  • the composition which is the subject of the invention further comprises an aqueous extract of at least one plant.
  • the components of the claimed composition are preferably of exclusively natural origin. They provide, in a balanced mixture, proteins and calcium mainly from the shell, to which are added the minerals: sodium, potassium, magnesium, phosphorus, sulfur and trace elements: selenium, manganese, iron, zinc, copper from essentially vinegar and sea salt.
  • the composition is in the form of a solution of pH 5.5.
  • composition according to the invention may result from different procedures, but it is particularly recommended to comply with the preparation process which will be described below, insofar as it makes it possible to obtain all the useful components of the process.
  • composition according to the invention in specific proportions.
  • acetic acid is supplied in the form of white wine vinegar, red wine vinegar or cider vinegar.
  • the sodium is provided as a gray salt.
  • the proteins and calcium are provided essentially by the shell of poultry eggs.
  • Eggs are commonly poultry eggs, and may be chosen for example from chicken eggs and guinea fowl eggs.
  • the method according to the invention may comprise a step prior to mixing, in which at least one plant is macerated in dilute acetic acid.
  • Another object of the present invention is a product for therapeutic or cosmetic use containing the composition as described above.
  • the products may contain ingredients such as a perfume or thickener, or other formulation additive known to those skilled in the art.
  • composition according to the invention may also be associated or not with one or more active components intended to potentiate its effects, such as essential oils and plant extracts.
  • active components intended to potentiate its effects, such as essential oils and plant extracts.
  • the products obtained, which contain said composition associated with another active ingredient, can therefore be proposed according to the specific need to be treated, in one or more of their indications.
  • the product according to the invention may further comprise one or more ingredients selected from: an essential oil, a plant extract, a perfume, a thickener.
  • the composition according to the invention can be used for the preparation of a medicament for the treatment of alopecia, skin diseases or scalp diseases. It is indicated in particular in the treatment of dermatoses such as seborrheic eczema, seborrheic parakeratosis, psoriasis of the scalp, seborrheic dermatitis, as well as in the treatment of diffuse or circumscribed alopecia accompanied by pityriasis, pruritus and / or seborrhea.
  • dermatoses such as seborrheic eczema, seborrheic parakeratosis, psoriasis of the scalp, seborrheic dermatitis, as well as in the treatment of diffuse or circumscribed alopecia accompanied by pityriasis, pruritus and
  • composition according to the invention can also be used for the preparation of a product for cosmetic use intended for treating the skin or the scalp.
  • the composition is specially designed to be applied to the scalp and skin.
  • the active ingredients namely proteins, calcium, minerals, trace elements and acetic acid, are in the form of a pH 5.5 solution favoring their dermal absorption and their bioavailability.
  • the necessary dose of oligomers being small and still moderate, the composition has the particularity of involving small amounts of elements already naturally present in the body, which pleads in favor of good tolerance.
  • the invention is illustrated without being limited in any way by the following examples which describe the formulation of a hair fall arrest composition together with a report of clinical experiments and the formulation of an antipruritic composition used in the treatment of eczema.
  • compositions based on proteins and calcium of the eggshell, minerals, trace elements and acetic acid are carried out as follows. Sodium is added as sea salt; acetic acid is added as vinegar.
  • composition obtained as indicated above contains in weight content: acetic acid: 4.70%
  • Protein and calcium are here in a protein / calcium ratio of 0.8.
  • alkylphenol polyglycol ether 5.00 g
  • the lotion used in prevention or treatment against hair loss.
  • the lotion may also be provided in the treatment of seborrhea, pruritus and pityriasis, whether these indications are associated or isolated.
  • a) Prepare a vinegar of plants by maceration for one month in a liter of white wine vinegar 7 °: 5g of wild pansy flowers, 5g of sarsaparilla roots, 5g of elm pyramidal barks, 5g of juniper berries, 5g d sweet woodruff.
  • b) Proceed to the mixing of the ingredients, as described in Example 1 using as vinegar, the plant vinegar above.
  • the composition C2 is obtained.
  • c) Proceed with the preparation of the lotion according to the formulation:
  • composition C2 25.00 g
  • a cream for topical application is obtained in the treatment of pruritus and eczema.
  • the cream can be proposed in these indications that they are associated or isolated.
  • composition according to the invention is based on clinical experiments conducted at the Saint Louis Hospital in Paris in the department of diseases of the scalp. 1) Protocol:
  • a hair lotion was prepared according to Example 2 above and tested on 40 people (22 males, 18 females), aged 13 to 65 years. Patients, male or female, were selected based on a moderate to severe tendency to hair loss. For men, androgenetic alopecia is observed in all cases. For women, the majority have Ludwig's Type I female alopecia. Of these, four are menopausal or already menopausal.
  • the patient applies each evening a third dropper pipette (ie 2 ml) the lotion. It is reviewed on the 2 nd and 3 rd month (according to need 5 th , 6 th , 7 th or 10 th month) after the first consultation. Seborrhea, pruritus, pityriasis and assessment of hair loss are graded at each consultation on a scale of 0 to 4. A sample for a trichogram is taken at the first consultation and after three months of treatment.
  • the trichograms allowing the study of the impact on the hair formula, are made by taking a lock of hair with the forceps in the frontal zone of the hair and, if possible, in one of the temporal zones. All samples of the same patient are made by the same doctor, who also performs trichograms. This one also carries out the anamnesis and the clinical examination.
  • Seborrhea decreased in 68.3% of cases, or "very little” in 58% of cases, or a good 10% of cases. This anti-seborrhoeic effect, however, has little effect on the frequency of shampoos.
  • a reduction in hair loss is reported by 59.5% of patients. It is considered “diminished” by 47.5% of patients and as “very diminished” by 12.5% of patients. This effect is observed as early as the second month. It stays in the 5 th and 6 th months.
  • the anti-hair loss effect is found in trichograms for one-third of the patients in the frontal area and for half in the temporal areas. Whatever the age and sex of the patients, the efficacy of the lotion tested is even better than the trend of alopecia is recent, with the persistence of a good capital hair. The five-month course provides the most satisfactory results.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a composition containing in a soluble form and in an aqueous phase: - proteins: 0.40% to 0.45%; - calcium: 0.50% to 0.51%; -the following mineral salts: sodium, potassium, magnesium, phosphorus, sulphur; - the following trace elements: selenium, manganese, iron, zinc, copper; - acetic acid: 4.70%. The invention also relates to a method for obtaining the composition that comprises placing raw poultry eggs with their shells in a tank containing diluted acetic acid and sodium chloride for one month so that the composition contains the solubilised forms of the compounds naturally occurring in the shell of a poultry egg. The composition of the invention can be used for preparing a drug or a cosmetic product for treating skin or scalp alopecia.

Description

COMPOSITION POUR LE TRAITEMENT DU CUIR CHEVELU COMPOSITION FOR THE TREATMENT OF SCALP
ET DE LA PEAUAND SKIN
La présente invention appartient au domaine des formulations destinées à une application topique à des fins thérapeutiques ou non thérapeutiques, préparées par extraction de composés utiles à partir de matières d'origine naturelle.The present invention belongs to the field of formulations intended for topical application for therapeutic or non-therapeutic purposes, prepared by extraction of useful compounds from naturally occurring materials.
Elle a pour objet une composition à base de protéines, de calcium, de minéraux et d'oligo- éléments en solution dans l'acide acétique dilué, ainsi qu'un procédé de préparation à partir d'ingrédients d'origine exclusivement naturelle. Un produit comprenant ladite composition, destiné au traitement thérapeutique ou cosmétique de la peau et du cuir chevelu, est également revendiqué.It relates to a composition based on proteins, calcium, minerals and oligomers in solution in dilute acetic acid, and a process for preparing from ingredients of exclusively natural origin. A product comprising said composition, intended for the therapeutic or cosmetic treatment of the skin and the scalp, is also claimed.
Protéines, calcium, sels minéraux et oligo-éléments sont présents à l'état naturel dans notre organisme et sont indispensables à son bon fonctionnement. Le calcium en est un acteur clé. On le retrouve impliqué dans de multiples actions métaboliques intervenant notamment dans la construction de la structure de la peau.Protein, calcium, mineral salts and trace elements are naturally present in our body and are essential for its proper functioning. Calcium is a key player. It is found involved in multiple metabolic actions involved in particular in the construction of the structure of the skin.
Actuellement de nombreuses théories tentent de rendre compte de l'ensemble des phénomènes complexes intervenant dans les processus qui conduisent au vieillissement et à la détérioration du fonctionnement des cellules d'organes vitaux, les poussant dans certaines conditions défavorables au suicide cellulaire (apoptose).Currently many theories attempt to account for all the complex phenomena involved in the processes that lead to aging and deterioration of the functioning of the cells of vital organs, pushing them under certain conditions unfavorable to cell suicide (apoptosis).
D'après les scientifiques, les carences nutritionnelles ou l'hyperproduction de radicaux libres seraient responsables d'un grand nombre de dommages causés aux cellules. On parle de sénescence réplicative et métabolique. Qu'ils soient apportés par l'environnement (pollution, fumée de cigarette, rayonnements...) ou engendrés par les cellules au cours de leurs réactions métaboliques, les radicaux libres peuvent perturber la réplication de l'ADN lors des divisions cellulaires et réduire leur capacité à se régénérer. Ils peuvent aussi détruire les membranes cellulaires, déformer les protéines cellulaires chargées du transport du calcium lequel se trouve dans l'incapacité de jouer son rôle de messager intercellulaire. Les cellules ne communiquent plus, perdent leur cohésion, se désorganisent lésant gravement les tissus. Au niveau de la peau, l'ensemble de ces bouleversements conduit à l'accélération du vieillissement cutané et dans certaines conditions à l'altération des tissus et à l'apparition de maladies, dermatoses, eczéma, psoriasis, prurit, alopécie.According to scientists, nutritional deficiencies or hyperproduction of free radicals would be responsible for a large number of cell damage. We talk about replicative and metabolic senescence. Whether brought by the environment (pollution, cigarette smoke, radiation ...) or generated by the cells during their metabolic reactions, free radicals can disrupt DNA replication during cell divisions and reduce their ability to regenerate. They can also destroy cell membranes, deform cellular proteins responsible for calcium transport which is unable to play its role of intercellular messenger. The cells do not communicate anymore, lose their cohesion, disorganize seriously injuring the tissues. At the level of the skin, all these upheavals lead to the acceleration of cutaneous aging and under certain conditions to the deterioration of the tissues and to the appearance of diseases, dermatoses, eczema, psoriasis, pruritus, alopecia.
II est maintenant établi qu'une corrélation existe entre le vieillissement cellulaire et l'alopécie. Les cellules reproductrices des follicules pileux sont normalement programmées pour se régénérer et faire naître de nouveaux cheveux d'une manière ininterrompue grâce à des cycles de pousse fixés entre 25 à 30 cycles, lesquels ayant une durée de 2 à 5 ans, sont en nombre suffisant pour renouveler la chevelure pendant toute une vie. Avec l'âge, les récepteurs hormonaux de ces organes cibles deviennent particulièrement sensibles à l'action nocive de la dihydrotestostérone issue de la testostérone sous l'effet de la 5-αréductase. Le ralentissement du rythme des divisions cellulaires et la dégradation du fonctionnement des follicules pileux se traduisent par la diminution des cycles de pousse qui rapidement s'épuisent, passant de quelques années à quelques mois. La chevelure s'éclaircit et, si on n'enraye pas la chute, on assiste à la perte définitive des cheveux.It is now established that a correlation exists between cellular aging and alopecia. The reproductive cells of the hair follicles are normally programmed to regenerate and give birth to new hair in an uninterrupted way thanks to cycles of growth set between 25 to 30 cycles, which have a duration of 2 to 5 years, are sufficient in number to renew the hair for a lifetime. With age, the hormonal receptors of these target organs become particularly sensitive to the harmful action of dihydrotestosterone resulting from testosterone under the effect of 5-α-reductase. Slowing down the rate of cell divisions and the deterioration of the functioning of the hair follicles results in a decrease in growth cycles that quickly run out, from a few years to a few months. The hair clears and, if we do not stop the fall, we see the final loss of hair.
Par ailleurs, l'étude de la composition de la coquille d'œuf montre qu'elle renferme en moyenne 3,3% de protéines constituant sa trame. Ces protéines jouent un rôle majeur dans les processus de la calcification de la coquille en faisant cristalliser environ 95,1% de minéraux, essentiellement des cristaux de carbonate de calcium sous forme de calcite. Les protéines et le calcium absorbés au sein de la matrice organique sont donc très étroitement impliqués dans la construction de la microstructure cristalline de la coquille laquelle contribue à sa solidité.In addition, the study of the composition of the eggshell shows that it contains on average 3.3% of proteins constituting its frame. These proteins play a major role in the processes of calcification of the shell by crystallizing about 95.1% of minerals, mainly calcium carbonate crystals in the form of calcite. The proteins and calcium absorbed within the organic matrix are therefore very closely involved in the construction of the crystalline microstructure of the shell, which contributes to its strength.
De manière inattendue, il a été mis en évidence que l'association des composés solubles de la coquille d'œuf avec des sels minéraux et des oligo-éléments apportés par des ingrédients naturels en milieu acide, permettait de traiter avec succès certaines affections du cuir chevelu et de la peau. Sans qu'une étude systématique ait été réalisée, on peut formuler l'hypothèse que la composition selon la présente invention permet de reproduire au niveau des structures de la peau, les mécanismes de solidité naturelle résultant de l'affinité des protéines et du calcium dans la constitution de la coquille. En outre, par sa formule, la composition selon l'invention apporte au cœur des cellules endommagées ou en panne, tous les éléments nutritifs nécessaires au rétablissement du fonctionnement cellulaire. En rétablissant le métabolisme du calcium, la composition revendiquée renforce la cohésion des tissus cutanés et aide à lutter contre le vieillissement cutané.Unexpectedly, it has been demonstrated that the combination of the soluble compounds of the eggshell with mineral salts and trace elements brought by natural ingredients in acidic medium, allowed to successfully treat certain conditions of the leather. hairy and skin. Without a systematic study having been carried out, it can be formulated that the composition according to the present invention makes it possible to reproduce, at the level of the structures of the skin, the mechanisms of natural solidity resulting from the affinity of proteins and calcium in the constitution of the shell. In addition, by its formula, the composition according to the invention brings to the heart damaged or broken cells, all the nutrients necessary for the restoration of functioning. cellular. By restoring the calcium metabolism, the claimed composition reinforces the cohesion of the cutaneous tissues and helps to fight against skin aging.
Plus précisément, la présente invention a pour objet une composition destinée à la préparation d'un produit à usage thérapeutique ou cosmétique, contenant, sous forme soluble en phase aqueuse :More specifically, the subject of the present invention is a composition intended for the preparation of a product for therapeutic or cosmetic use, containing, in soluble form in aqueous phase:
- des protéines : 0,40% à 0,45% ;proteins: 0.40% to 0.45%;
- du calcium : 0,50% à 0,51% ;calcium: 0.50% to 0.51%;
- les sels minéraux suivants : sodium, potassium, magnésium, phosphore, soufre ; - les oligo-éléments suivants : sélénium, manganèse, fer, zinc, cuivre ;- the following minerals: sodium, potassium, magnesium, phosphorus, sulfur; - the following trace elements: selenium, manganese, iron, zinc, copper;
- de l'acide acétique : 4,70%.acetic acid: 4.70%.
De préférence, la composition selon l'invention comprend les sels minéraux énumérés avec les teneurs respectives suivantes : - sodium : 1 ,70% à 2,50%Preferably, the composition according to the invention comprises the listed mineral salts with the following respective contents: sodium: 1, 70% to 2.50%
- potassium: 0,11 %- potassium: 0.11%
- magnésium : 0,05%- magnesium: 0.05%
- phosphore : 0,055% à 0,060% - soufre : 0,10%- phosphorus: 0.055% to 0.060% - sulfur: 0.10%
De préférence également, la composition selon l'invention comprend les oligo-éléments énumérés avec les teneurs respectives suivantes:Also preferably, the composition according to the invention comprises the trace elements listed with the respective contents as follows:
- sélénium : 29,0 ppmselenium: 29.0 ppm
- manganèse : 4,5 ppm - fer : 4,4 ppm- manganese: 4.5 ppm - iron: 4.4 ppm
- zinc : 2,0 ppm- zinc: 2.0 ppm
- cuivre : 0,4 ppm- copper: 0.4 ppm
Selon une caractéristique intéressante de la composition selon l'invention, le rapport protéines/calcium est compris dans l'intervalle allant de 0,8 à 0,9.According to an advantageous characteristic of the composition according to the invention, the protein / calcium ratio is in the range from 0.8 to 0.9.
Selon une caractéristique particulièrement intéressante, dans la composition objet de l'invention, les protéines et le calcium comprennent les formes solubilisées de composés se trouvant naturellement dans la coquille d'œuf de volaille. En effet, la composition se caractérise en ce qu'elle contient de 0,40 % à 0,45 % de protéines provenant essentiellement de la coquille d'œuf et de 0,50 % à 0,51 % de calcium provenant de la calcite de la coquille d'œuf, en solution dans l'eau additionnée de 4,70% d'acide acétique. Cet état de fait permet de souligner encore l'origine naturelle de la composition revendiquée.According to a particularly advantageous characteristic, in the composition which is the subject of the invention, the proteins and calcium comprise the solubilized forms of compounds naturally occurring in the poultry eggshell. Indeed, the composition is characterized in that it contains from 0.40% to 0.45% of proteins originating from essentially eggshell and 0.50% to 0.51% calcium from eggshell calcite dissolved in water with 4.70% acetic acid. This state of affairs makes it possible to further underline the natural origin of the composition claimed.
Selon un mode de réalisation avantageux, la composition objet de l'invention comprend en outre un extrait aqueux d'au moins un végétal.According to an advantageous embodiment, the composition which is the subject of the invention further comprises an aqueous extract of at least one plant.
Selon l'invention, les composants de la composition revendiquée sont de préférence d'origine exclusivement naturelle. Ils apportent, en un mélange équilibré, protéines et calcium provenant essentiellement de la coquille, auxquels viennent s'ajouter les minéraux : sodium, potassium, magnésium, phosphore, soufre et les oligo-éléments : sélénium, manganèse, fer, zinc, cuivre provenant essentiellement du vinaigre et du sel marin.According to the invention, the components of the claimed composition are preferably of exclusively natural origin. They provide, in a balanced mixture, proteins and calcium mainly from the shell, to which are added the minerals: sodium, potassium, magnesium, phosphorus, sulfur and trace elements: selenium, manganese, iron, zinc, copper from essentially vinegar and sea salt.
Selon une caractéristique avantageuse de l'invention, la composition est sous la forme d'une solution de pH 5,5.According to an advantageous characteristic of the invention, the composition is in the form of a solution of pH 5.5.
L'obtention de la composition telle que décrite peut découler de différents modes opératoires, mais il est particulièrement recommandé de se conformer au procédé de préparation qui sera décrit ci-après, dans la mesure où il permet d'obtenir tous les composants utiles de la composition selon l'invention dans des proportions déterminées.Obtaining the composition as described may result from different procedures, but it is particularly recommended to comply with the preparation process which will be described below, insofar as it makes it possible to obtain all the useful components of the process. composition according to the invention in specific proportions.
Ainsi est revendiqué un procédé d'obtention d'une composition telle que précédemment décrite, comprenant essentiellement les étapes consistant à :Thus is claimed a method for obtaining a composition as previously described, essentially comprising the steps of:
- introduire dans une cuve de l'acide acétique dilué ;- introduce into a tank diluted acetic acid;
- ajouter du chlorure de sodium et agiter jusqu'à dissolution complète ;- add sodium chloride and stir until completely dissolved;
- introduire des œufs de volaille crus munis de leur coquille sans les casser ;- introduce raw poultry eggs with their shells without breaking them;
- laisser reposer un mois ; - retirer les œufs en prenant soin de ne pas perforer les membranes coquillières ;- let rest a month; - remove the eggs, taking care not to perforate the shell membranes;
- filtrer la solution ainsi obtenue.- filter the solution thus obtained.
Selon une caractéristique préférée du procédé revendiqué, l'acide acétique est apporté sous forme de vinaigre de vin blanc, de vinaigre de vin rouge ou de vinaigre de cidre. Selon une autre caractéristique préférée du procédé revendiqué, le sodium est apporté sous forme de sel gris marin.According to a preferred characteristic of the claimed process, acetic acid is supplied in the form of white wine vinegar, red wine vinegar or cider vinegar. According to another preferred feature of the claimed process, the sodium is provided as a gray salt.
Dans un mode de réalisation particulièrement intéressant du procédé selon l'invention, les protéines et le calcium sont apportés essentiellement par la coquille des œufs de volaille.In a particularly advantageous embodiment of the method according to the invention, the proteins and calcium are provided essentially by the shell of poultry eggs.
Les œufs sont communément des œufs de volaille, et peuvent être choisis par exemple parmi les œufs de poule et les œufs de pintade.Eggs are commonly poultry eggs, and may be chosen for example from chicken eggs and guinea fowl eggs.
Selon un mode de réalisation préféré du procédé selon l'invention, on met en œuvre les ingrédients suivants :According to a preferred embodiment of the process according to the invention, the following ingredients are used:
- vinaigre de vin blanc à 7° : 1 litre- 7 ° white wine vinegar: 1 liter
- sel gris marin : 80 grammes- marine gray salt: 80 grams
- œufs de poule : 3 unités- chicken eggs: 3 units
De manière avantageuse, le procédé selon l'invention peut comprendre une étape préalable au mélange, dans laquelle on fait macérer au moins un végétal dans l'acide acétique dilué.Advantageously, the method according to the invention may comprise a step prior to mixing, in which at least one plant is macerated in dilute acetic acid.
Est également objet de la présente invention un produit à usage thérapeutique ou cosmétique contenant la composition telle que décrite précédemment.Another object of the present invention is a product for therapeutic or cosmetic use containing the composition as described above.
Pour les besoins de la formulation, les produits peuvent contenir des ingrédients tels qu'un parfum ou un épaississant, ou un autre additif de formulation connu de l'homme de l'art.For the purposes of the formulation, the products may contain ingredients such as a perfume or thickener, or other formulation additive known to those skilled in the art.
La composition selon l'invention peut en outre être associée ou non à un ou plusieurs composants actifs destinés à potentialiser ses effets, tels que des huiles essentielles et des extraits végétaux. Les produits obtenus, qui contiennent ladite composition associée à un autre actif, peuvent donc être proposées selon le besoin spécifique à traiter, dans une ou plusieurs de leurs indications.The composition according to the invention may also be associated or not with one or more active components intended to potentiate its effects, such as essential oils and plant extracts. The products obtained, which contain said composition associated with another active ingredient, can therefore be proposed according to the specific need to be treated, in one or more of their indications.
C'est pourquoi, de manière optionnelle, le produit selon l'invention peut comprendre en outre un ou plusieurs ingrédients choisis parmi : une huile essentielle, un extrait végétal, un parfum, un épaississant. La composition selon l'invention peut être utilisée pour la préparation d'un médicament destiné au traitement de l'alopécie, des maladies de la peau ou des maladies du cuir chevelu. Elle est indiquée notamment dans le traitement des dermatoses telles que l'eczéma séborrhéique, les parakératoses séborrhéiques, le psoriasis du cuir chevelu, la dermite séborrhéique, ainsi que dans le traitement des alopécies diffuses ou circonscrites accompagnées de pityriasis, de prurit et/ou de séborrhée.Therefore, optionally, the product according to the invention may further comprise one or more ingredients selected from: an essential oil, a plant extract, a perfume, a thickener. The composition according to the invention can be used for the preparation of a medicament for the treatment of alopecia, skin diseases or scalp diseases. It is indicated in particular in the treatment of dermatoses such as seborrheic eczema, seborrheic parakeratosis, psoriasis of the scalp, seborrheic dermatitis, as well as in the treatment of diffuse or circumscribed alopecia accompanied by pityriasis, pruritus and / or seborrhea.
La composition selon l'invention peut aussi être utilisée pour la préparation d'un produit à usage cosmétique destiné au traitement de la peau ou du cuir chevelu.The composition according to the invention can also be used for the preparation of a product for cosmetic use intended for treating the skin or the scalp.
Selon l'invention, la composition est spécialement conçue pour être appliquée sur le cuir chevelu et la peau. Les actifs, à savoir protéines, calcium, minéraux, oligo-éléments et acide acétique, sont sous forme d'une solution de pH 5,5 favorisant leur absorption cutanée et leur biodisponibilité. On notera en outre que la dose nécessaire d'oligo- éléments étant faible et toujours modérée, la composition présente la particularité de mettre en jeu de petites quantités d'éléments déjà naturellement présents dans l'organisme, ce qui plaide en faveur d'une bonne tolérance.According to the invention, the composition is specially designed to be applied to the scalp and skin. The active ingredients, namely proteins, calcium, minerals, trace elements and acetic acid, are in the form of a pH 5.5 solution favoring their dermal absorption and their bioavailability. It should further be noted that the necessary dose of oligomers being small and still moderate, the composition has the particularity of involving small amounts of elements already naturally present in the body, which pleads in favor of good tolerance.
L'invention est illustrée sans être aucunement limitée à l'aide des exemples suivants qui décrivent la formulation d'une composition capillaire antichute assortie d'un compte-rendu d'expérimentations cliniques et la formulation d'une composition antiprurigineuse utilisée dans le traitement de l'eczéma.The invention is illustrated without being limited in any way by the following examples which describe the formulation of a hair fall arrest composition together with a report of clinical experiments and the formulation of an antipruritic composition used in the treatment of eczema.
EXEMPLE 1 : Préparation d'une compositionEXAMPLE 1 Preparation of a composition
La préparation d'une composition à base de protéines et calcium de la coquille d'œuf, de minéraux, d'oligo-éléments et acide acétique est réalisée comme suit. Le sodium est ajouté sous forme de sel marin ; l'acide acétique est ajouté sous forme de vinaigre.The preparation of a composition based on proteins and calcium of the eggshell, minerals, trace elements and acetic acid is carried out as follows. Sodium is added as sea salt; acetic acid is added as vinegar.
1 ) On emploie les ingrédients dans les proportions suivantes :1) The ingredients are used in the following proportions:
- œufs de poule 3 unités- chicken eggs 3 units
- sel gris marin 80 grammes- marine gray salt 80 grams
- vinaigre de vin blanc 7° 1 litre 2) On opère ainsi : remplir une cuve de vinaigre de vin blanc, ajouter le sel, faire dissoudre par agitation. Ajouter les œufs crus munis de leurs coquilles en les immergeant un à un délicatement pour ne pas les casser. Laisser reposer un mois sans agiter. A ce stade on observe la dissolution complète des coquilles. Retirer les œufs un à un délicatement, cette fois afin de ne pas perforer les membranes coquillières. Filtrer la solution ainsi obtenue.- white wine vinegar 7 ° 1 liter 2) One operates as follows: fill a vat with white wine vinegar, add the salt, dissolve by stirring. Add the raw eggs with their shells, immersing them one by one so as not to break them. Leave to rest for a month without shaking. At this stage we observe the complete dissolution of the shells. Remove the eggs one by one delicately, this time so as not to perforate the shell membranes. Filter the solution thus obtained.
3) Analyse élémentaire de la composition3) Elemental analysis of the composition
La composition obtenue comme indiqué ci-dessus contient en teneur pondérale : - acide acétique : 4,70%The composition obtained as indicated above contains in weight content: acetic acid: 4.70%
- protéines : 0,40 % (dosage à partir de la teneur en azote total)- protein: 0.40% (determination from the total nitrogen content)
- calcium : 0,50 %- calcium: 0.50%
- sodium : 1 ,70 %- sodium: 1, 70%
- potassium : 0,1 1 % - magnésium : 0,05 %- potassium: 0.1% - magnesium: 0.05%
- phosphore : 0,06 % - soufre : 0,10 %- phosphorus: 0,06% - sulfur: 0,10%
- sélénium : 29,0 ppmselenium: 29.0 ppm
- manganèse : 4,5 ppm - fer : 4,4 ppm- manganese: 4.5 ppm - iron: 4.4 ppm
- zinc : 2,0 ppm- zinc: 2.0 ppm
- cuivre : 0,4 ppm- copper: 0.4 ppm
Les protéines et le calcium sont ici dans un rapport protéines/calcium de 0,8.Protein and calcium are here in a protein / calcium ratio of 0.8.
EXEMPLE 2 : Lotion capillaire antichuteEXAMPLE 2: Anti-hair loss hair lotion
a)- Faire macérer pendant un mois dans un litre de vinaigre de vin blanc à 7°, 5g d'ortie piquante racines, 5g d'ortie piquante feuilles, 5g de bardane, 5g de thym fleurs, 5g de capucine semences. On obtient une solution vinaigrée contenant des composés végétaux issus des plantes ayant macéré, appelée "vinaigre de plantes". b)- Procéder au mélange des ingrédients, comme décrit à l'Exemple 1 en utilisant comme vinaigre, le vinaigre de plante ci-dessus. On obtient la composition C1. c)- Procéder à la préparation de la lotion selon la formulation : - composition C1 : 100,00 g - huile essentielle de lavande : 0,40 ga) - Macerate for one month in a liter of white wine vinegar at 7 °, 5g of nettle, 5g of nettles, 5g of burdock, 5g of thyme flowers, 5g of nasturtium seeds. A vinegar solution is obtained containing plant compounds from plants having macerated, called "vinegar plants". b) - Proceed to the mixing of the ingredients, as described in Example 1 using as vinegar, the plant vinegar above. The composition C1 is obtained. c) - Proceed with the preparation of the lotion according to the formulation: - Composition C1: 100.00 g - essential oil of lavender: 0.40 g
- alkylphénol-polyglycoléther : 5,00 galkylphenol polyglycol ether: 5.00 g
- composition parfumante : 1 ,00 g- perfume composition: 1.00 g
On obtient une lotion capillaire utilisée en prévention ou en traitement contre la chute des cheveux. La lotion peut être aussi proposée dans le traitement de la séborrhée, du prurit et du pityriasis, que ces indications soient associées ou isolées.We obtain a hair lotion used in prevention or treatment against hair loss. The lotion may also be provided in the treatment of seborrhea, pruritus and pityriasis, whether these indications are associated or isolated.
EXEMPLE 3 : Pommade utilisée dans le traitement du prurit et de l'eczéma.EXAMPLE 3 Ointment used in the treatment of pruritus and eczema
a)- Préparer un vinaigre de plantes en faisant macérer pendant un mois dans un litre de vinaigre de vin blanc 7° : 5g de pensée sauvage fleurs, 5g de salsepareille racines, 5g d'orme pyramidale écorces, 5g de genièvre baies, 5g d'aspérule odorante. b)- Procéder au mélange des ingrédients, comme décrit à l'Exemple 1 en utilisant comme vinaigre, le vinaigre de plante ci-dessus. On obtient la composition C2. c)- Procéder à la préparation de la lotion selon la formulation :a) - Prepare a vinegar of plants by maceration for one month in a liter of white wine vinegar 7 °: 5g of wild pansy flowers, 5g of sarsaparilla roots, 5g of elm pyramidal barks, 5g of juniper berries, 5g d sweet woodruff. b) - Proceed to the mixing of the ingredients, as described in Example 1 using as vinegar, the plant vinegar above. The composition C2 is obtained. c) - Proceed with the preparation of the lotion according to the formulation:
- composition C2 : 25,00 gcomposition C2: 25.00 g
- huile essentielle de lavande : 0,40 g - huile essentielle de géranium : 0,15 g- essential oil of lavender: 0.40 g - essential oil of geranium: 0.15 g
- huile essentielle de niaouli : 0,10 g- essential oil of niaouli: 0,10 g
- huile essentielle de sauge : 0,10 g- essential oil of sage: 0,10 g
- huile d'olive : 25,00 g- olive oil: 25.00 g
- lanoline qsp : 100,00 g- lanolin qs: 100.00 g
On obtient une crème destinée à une application topique dans le traitement du prurit et de l'eczéma. La crème peut être proposée dans ces indications qu'elles soient associées ou isolées.A cream for topical application is obtained in the treatment of pruritus and eczema. The cream can be proposed in these indications that they are associated or isolated.
EXEMPLE 4 : Essais cliniquesEXAMPLE 4: Clinical Trials
La démonstration de l'efficacité de composition selon l'invention repose sur des expérimentations cliniques réalisées à l'hôpital Saint Louis à Paris dans le service des maladies du cuir chevelu. 1 ) Protocole :The demonstration of the effectiveness of composition according to the invention is based on clinical experiments conducted at the Saint Louis Hospital in Paris in the department of diseases of the scalp. 1) Protocol:
Une lotion capillaire a été préparée selon l'Exemple 2 ci-dessus et testée sur 40 personnes (22 de sexe masculin, 18 de sexe féminin), âgées de 13 à 65 ans. Les patients, hommes ou femmes, ont été sélectionnés d'après une tendance modérée à marquée à la chute des cheveux. Pour les hommes, l'alopécie androgénogénétique est observée dans tous les cas. Pour les femmes, la majorité est atteinte d'une alopécie féminine débutante Type I de Ludwig. Parmi elles, quatre sont en période de ménopause ou déjà ménopausées.A hair lotion was prepared according to Example 2 above and tested on 40 people (22 males, 18 females), aged 13 to 65 years. Patients, male or female, were selected based on a moderate to severe tendency to hair loss. For men, androgenetic alopecia is observed in all cases. For women, the majority have Ludwig's Type I female alopecia. Of these, four are menopausal or already menopausal.
Le patient applique chaque soir un tiers de pipette compte-gouttes (soit 2 ml) le lotion. Il est revu le 2eme et le 3eme mois (selon nécessité 5eme, 6eme, 7eme ou 10eme mois) après la première consultation. A chaque consultation sont notés la séborrhée, le prurit, le pityriasis et l'appréciation de la chute des cheveux, sur une échelle de 0 à 4. Un prélèvement pour un trichogramme est réalisé lors de la première consultation et après trois mois de traitement.The patient applies each evening a third dropper pipette (ie 2 ml) the lotion. It is reviewed on the 2 nd and 3 rd month (according to need 5 th , 6 th , 7 th or 10 th month) after the first consultation. Seborrhea, pruritus, pityriasis and assessment of hair loss are graded at each consultation on a scale of 0 to 4. A sample for a trichogram is taken at the first consultation and after three months of treatment.
Les trichogrammes permettant l'étude de l'impact sur la formule pilaire, sont réalisés par prélèvement d'une mèche de cheveux à la pince dans la zone frontale de la chevelure et, si possible, dans l'une des zones temporales. Tous les prélèvements d'un même patient sont effectués par le même médecin, qui réalise aussi les trichogrammes. Celui-ci réalise également l'anamnèse et l'examen clinique.The trichograms allowing the study of the impact on the hair formula, are made by taking a lock of hair with the forceps in the frontal zone of the hair and, if possible, in one of the temporal zones. All samples of the same patient are made by the same doctor, who also performs trichograms. This one also carries out the anamnesis and the clinical examination.
2) Résultats2) Results
- La séborrhée- Seborrhea
La séborrhée a diminué dans 68,3 % des cas, soit "peu" pour 58 % des cas, soit beaucoup pour 10 % des cas. Cet effet anti séborrhéique influence cependant peu la fréquence des shampooings.Seborrhea decreased in 68.3% of cases, or "very little" in 58% of cases, or a good 10% of cases. This anti-seborrhoeic effect, however, has little effect on the frequency of shampoos.
- Pityriasis capitis- Pityriasis capitis
L'état pelliculaire est réduit dans 82 % des cas, dont 46,4 % des cas sont "bien diminué" et 35,7 % des cas sont "très diminués". Cet effet est observé précocement, à savoir dès la fin du premier mois, et se maintient. - Le pruritPellicular state is reduced in 82% of cases, of which 46.4% of cases are "well diminished" and 35.7% of cases are "very diminished". This effect is observed early, ie from the end of the first month, and is maintained. - Pruritus
Pour 79 % des cas, le prurit est réduit, avec un tiers des patients le considérant comme supprimé et 45,8 % des cas le signalant "diminué". Cet effet antiprurigineux est obtenu dès la fin du premier mois. - Effet anti chuteFor 79% of cases, pruritus is reduced, with one third of patients considering it as suppressed and 45.8% of cases reporting it "decreased". This antipruritic effect is obtained at the end of the first month. - Anti fall effect
Une réduction de la chute des cheveux est signalée par 59,5 % des patients. Elle est considérée comme "diminuée" par 47,5 % des patients et comme "très diminuée" par 12,5 % des patients. Cet effet est constaté dès le deuxième mois. Il se maintient au 5eme et 6eme mois.A reduction in hair loss is reported by 59.5% of patients. It is considered "diminished" by 47.5% of patients and as "very diminished" by 12.5% of patients. This effect is observed as early as the second month. It stays in the 5 th and 6 th months.
Au total les effets cliniques sont définis comme rapides par les patients. Ils qualifient leurs cheveux comme étant "plus brillants, plus doux, plus souples, plus toniques, plus épais et donnant un aspect de volume à la chevelure".Overall the clinical effects are defined as fast by the patients. They call their hair "brighter, softer, more supple, more toned, thicker and giving the hair a volume look".
3) Conclusions3) Conclusions
Au terme de l'étude clinique et l'anamnèse, les résultats obtenus sont remarquables.At the end of the clinical study and the anamnesis, the results obtained are remarkable.
Les effets antiprurigineux et antipelliculaire sont les plus satisfaisants. Compte tenu des améliorations constatées, la lotion testée peut être proposée en traitement local dans ces indications, qu'elles soient associées ou isolées.Antipruritic and anti-dandruff effects are most satisfactory. Given the improvements noted, the lotion tested can be proposed in local treatment in these indications, whether associated or isolated.
L'effet anti chute des cheveux est constaté aux trichogrammes pour un tiers des patients dans la zone frontale et pour la moitié dans les zones temporales. Quels que soient l'âge et le sexe des patients, l'efficacité de la lotion testée est d'autant meilleure que la tendance à l'alopécie est récente, avec la persistance d'un bon capital cheveu. La cure de cinq mois apporte les résultats les plus satisfaisants.The anti-hair loss effect is found in trichograms for one-third of the patients in the frontal area and for half in the temporal areas. Whatever the age and sex of the patients, the efficacy of the lotion tested is even better than the trend of alopecia is recent, with the persistence of a good capital hair. The five-month course provides the most satisfactory results.
Les femmes obtiennent aussi de bons résultats lorsqu'elles sont en période de ménopause ou déjà ménopausées. La formule s'emploie donc aussi bien chez les hommes que chez les femmes, et à tout âge. Women also perform well when they are menopausal or already menopausal. The formula is therefore used in men as well as women, and at any age.

Claims

REVENDICATIONS
1 - Composition destinée à la préparation d'un produit à usage thérapeutique ou cosmétique, caractérisée en ce qu'elle contient, sous forme soluble en phase aqueuse : - des protéines : 0,40% à 0,45% ;1 - Composition for the preparation of a product for therapeutic or cosmetic use, characterized in that it contains, in soluble form in aqueous phase: - proteins: 0.40% to 0.45%;
- du calcium : 0,50% à 0,51% ;calcium: 0.50% to 0.51%;
- les sels minéraux suivants : sodium, potassium, magnésium, phosphore, soufre ;- the following minerals: sodium, potassium, magnesium, phosphorus, sulfur;
- les oligo-éléments suivants : sélénium, manganèse, fer, zinc, cuivre ;- the following trace elements: selenium, manganese, iron, zinc, copper;
- de l'acide acétique : 4,70%.acetic acid: 4.70%.
2 - Composition selon la revendication 1 , caractérisée en ce que les sels minéraux ont les teneurs respectives suivantes :2 - Composition according to claim 1, characterized in that the inorganic salts have the following respective contents:
- sodium : 1 ,70% à 2,50%sodium: 1, 70% to 2.50%
- potassium: 0,11 % - magnésium : 0,05%- potassium: 0.11% - magnesium: 0.05%
- phosphore : 0,055% à 0,060% - soufre : 0,10%- phosphorus: 0.055% to 0.060% - sulfur: 0.10%
3 - Composition selon la revendication 1 ou 2, caractérisée en ce que les oligo- éléments ont les teneurs respectives suivantes:3 - Composition according to claim 1 or 2, characterized in that the trace elements have the following respective contents:
- sélénium : 29,0 ppmselenium: 29.0 ppm
- manganèse : 4,5 ppm- manganese: 4.5 ppm
- fer : 4,4 ppmiron: 4.4 ppm
- zinc : 2,0 ppm- zinc: 2.0 ppm
- cuivre : 0,4 ppm- copper: 0.4 ppm
4 - Composition selon l'une des revendications précédentes, caractérisée en ce que les protéines et le calcium comprennent les formes solubilisées de composés se trouvant naturellement dans la coquille d'œuf de volaille.4 - Composition according to one of the preceding claims, characterized in that the proteins and calcium comprise the solubilized forms of compounds naturally occurring in the poultry egg shell.
5 - Composition selon l'une des revendications précédentes, caractérisée en ce que le rapport protéines/calcium est compris dans l'intervalle allant de 0,8 à 0,9.5 - Composition according to one of the preceding claims, characterized in that the protein / calcium ratio is in the range of 0.8 to 0.9.
6 - Composition selon l'une des revendications précédentes, caractérisée en ce fliïelle comprend en outre un extrait aqueux d'au moins un végétal. 7 - Composition selon l'une des revendications précédentes, caractérisée en ce que ses composants sont d'origine exclusivement naturelle.6 - Composition according to one of the preceding claims, characterized in that it further comprises an aqueous extract of at least one plant. 7 - Composition according to one of the preceding claims, characterized in that its components are of exclusively natural origin.
8 - Composition selon l'une des revendications précédentes, caractérisée en ce qjïelle est sous la forme d'une solution de pH 5,5.8. Composition according to one of the preceding claims, characterized in that it is in the form of a solution of pH 5.5.
9 - Procédé d'obtention d'une composition selon l'une des revendications 1 à 8, caractérisé en ce qu'il comprend essentiellement les étapes consistant à : - introduire dans une cuve de l'acide acétique dilué ;9 - Process for obtaining a composition according to one of claims 1 to 8, characterized in that it comprises essentially the steps of: - introducing into a tank of dilute acetic acid;
- ajouter du chlorure de sodium et agiter jusqu'à dissolution complète ;- add sodium chloride and stir until completely dissolved;
- introduire des œufs de volaille crus munis de leur coquille sans les casser ;- introduce raw poultry eggs with their shells without breaking them;
- laisser reposer un mois ;- let rest a month;
- retirer les œufs en prenant soin de ne pas perforer les membranes coquillières ; - filtrer la solution ainsi obtenue.- remove the eggs, taking care not to perforate the shell membranes; - filter the solution thus obtained.
10 - Procédé selon la revendication 9, caractérisé en ce que l'acide acétique est apporté sous forme de vinaigre de vin blanc, de vinaigre de vin rouge ou de vinaigre de cidre.10 - Process according to claim 9, characterized in that the acetic acid is supplied in the form of white wine vinegar, red wine vinegar or cider vinegar.
1 1 - Procédé selon l'une des revendications 9 ou 10, caractérisé en ce que le sodium est apporté sous forme de sel gris marin.1 1 - Process according to one of claims 9 or 10, characterized in that the sodium is provided in the form of marine gray salt.
12 - Procédé selon la revendication 9, caractérisé en ce que les protéines et le calcium sont apportés essentiellement par la coquille des œufs de volaille.12 - Process according to claim 9, characterized in that the proteins and calcium are provided essentially by the shell of poultry eggs.
13 - Procédé selon la revendication 9, caractérisé en ce que les œufs sont choisis parmi les œufs de poule et les œufs de pintade.13 - Process according to claim 9, characterized in that the eggs are chosen from chicken eggs and guinea fowl eggs.
14 - Procédé selon l'une des revendications 9 à 13, caractérisé en ce qu'on met en œuvre les ingrédients suivants :14 - Method according to one of claims 9 to 13, characterized in that implements the following ingredients:
- vinaigre de vin blanc à 7° 1 litre- white wine vinegar at 7 ° 1 liter
- sel gris marin 80 grammes- marine gray salt 80 grams
- œufs de poule 3 unités 15 - Procédé selon l'une des revendications 9 à 14, caractérisé en ce que, préalablement au mélange, on fait macérer au moins un végétal dans l'acide acétique dilué.- chicken eggs 3 units 15 - Process according to one of claims 9 to 14, characterized in that, prior to mixing, is macerated at least one plant in dilute acetic acid.
16 - Produit à usage thérapeutique ou cosmétique contenant la composition selon l'une des revendications 1 à 8.16 - Product for therapeutic or cosmetic use containing the composition according to one of claims 1 to 8.
17 - Produit selon la revendication précédente caractérisé en ce qu'il comprend en outre un ou plusieurs ingrédients choisis parmi : une huile essentielle, un extrait végétal, un parfum, un épaississant.17 - Product according to the preceding claim characterized in that it further comprises one or more ingredients selected from: an essential oil, a plant extract, a perfume, a thickener.
18 - Utilisation d'une composition selon l'une des revendications 1 à 8 pour la préparation d'un médicament destiné au traitement de l'alopécie, des maladies de la peau ou des maladies du cuir chevelu.18 - Use of a composition according to one of claims 1 to 8 for the preparation of a medicament for the treatment of alopecia, skin diseases or diseases of the scalp.
19 - Utilisation d'une composition selon l'une des revendications 1 à 8 pour la préparation d'un produit à usage cosmétique destiné au traitement de la peau ou du cuir chevelu. 19 - Use of a composition according to one of claims 1 to 8 for the preparation of a product for cosmetic use for the treatment of the skin or scalp.
PCT/EP2008/050237 2008-01-10 2008-01-10 Composition for treating scalp and skin WO2009086934A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/EP2008/050237 WO2009086934A1 (en) 2008-01-10 2008-01-10 Composition for treating scalp and skin
IL206695A IL206695A (en) 2008-01-10 2010-06-29 Composition for treating scalp and skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2008/050237 WO2009086934A1 (en) 2008-01-10 2008-01-10 Composition for treating scalp and skin

Publications (1)

Publication Number Publication Date
WO2009086934A1 true WO2009086934A1 (en) 2009-07-16

Family

ID=39798265

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/050237 WO2009086934A1 (en) 2008-01-10 2008-01-10 Composition for treating scalp and skin

Country Status (2)

Country Link
IL (1) IL206695A (en)
WO (1) WO2009086934A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533437A1 (en) * 1982-09-28 1984-03-30 Hecmati Michel Dentifrice composition containing exclusively natural products and which has the appearance of a black gel or paste
GB2218906A (en) * 1988-05-27 1989-11-29 Anne Mcmanus Medicament for treatment of skin disorders
US5662954A (en) * 1994-07-05 1997-09-02 Joiner; Margie Method for preparing mineral-enriched citrate compositions
WO1998025586A1 (en) * 1996-12-10 1998-06-18 Patricia Dupuy Preparation for dermatological use
US6036966A (en) * 1998-02-17 2000-03-14 Youssefyeh; Rena T. Skin treatment compositions comprising protein and enzyme extracts
JP2002212069A (en) * 2001-12-10 2002-07-31 Noevir Co Ltd Skin care perparation
JP2004229534A (en) * 2003-01-29 2004-08-19 Yukio Hasebe Hydrolyzed eggshell membrane-containing drink
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533437A1 (en) * 1982-09-28 1984-03-30 Hecmati Michel Dentifrice composition containing exclusively natural products and which has the appearance of a black gel or paste
GB2218906A (en) * 1988-05-27 1989-11-29 Anne Mcmanus Medicament for treatment of skin disorders
US5662954A (en) * 1994-07-05 1997-09-02 Joiner; Margie Method for preparing mineral-enriched citrate compositions
WO1998025586A1 (en) * 1996-12-10 1998-06-18 Patricia Dupuy Preparation for dermatological use
US6036966A (en) * 1998-02-17 2000-03-14 Youssefyeh; Rena T. Skin treatment compositions comprising protein and enzyme extracts
JP2002212069A (en) * 2001-12-10 2002-07-31 Noevir Co Ltd Skin care perparation
JP2004229534A (en) * 2003-01-29 2004-08-19 Yukio Hasebe Hydrolyzed eggshell membrane-containing drink
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
WO2004080428A2 (en) * 2003-03-12 2004-09-23 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Hair tonic composition comprising egg and rice vinegar - useful for promoting hair growth, and as a hair treatment", 18 May 1999, DERWENT, XP002223535 *
YI F ET AL: "Soluble eggshell membrane protein: preparation, characterization and biocompatibility", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 25, no. 19, 1 August 2004 (2004-08-01), pages 4591 - 4599, XP004505469, ISSN: 0142-9612 *

Also Published As

Publication number Publication date
IL206695A (en) 2015-11-30
IL206695A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
FR2758720A1 (en) Anti-dandruff composition
CA2306414A1 (en) Compositions based on plant extracts
EP0817641B1 (en) Substances extracted from dictyotales, preparation method therefor, and compositions containing same
WO2013150253A1 (en) Novel oligosaccharide compounds and the cosmetic use thereof
EP3878431A1 (en) Deodorant cosmetic composition comprising zinc ricinoleate
FR2825022A1 (en) Nontherapeutic treatment of the human or animal body comprises administering or applying olive polyphenols
EP2747739B1 (en) Dermocosmetic compositions based on a synergistic combination of colloidal silver and deoxyribonucleic acid
WO2009086934A1 (en) Composition for treating scalp and skin
WO2000030604A1 (en) Composition for preventing and treating cellulitis
EP2139503B1 (en) Cosmetic and dermatological compositions based on algae extracts
FR2981275A1 (en) MEROTERPENE-BASED COMPOSITION FOR OILY SKIN, ACNETIC SKIN OR ACNE-DENIED
EP3595627B1 (en) Association of aqueous extracts of cress and nasturtium and atp in the treatment of alopecia
FR2908044A1 (en) Complex, useful to prepare composition to treat alopecia, comprises protein, calcium, mineral comprising sodium, potassium, magnesium, phosphorus and sulfur, oilgo-element having selenium, manganese, iron, zinc and copper and acetic acid
FR2875134A1 (en) Use of a composition comprising a hydrosoluble derivative of ascorbic acid and porous polyamide particles in a medium, for the care of fatty skins in cosmetics
FR2920089A1 (en) USE OF 2.2-CYCLOLIGNANES AS PROMOTERS FOR THE PIGMENTATION OF SKIN OR HAIR
FR2778101A1 (en) COMPOSITION CONTAINING PROCYANIDOLIC OLIGOMERS (OPC) AND A DIVALENT CATION, ITS USE AS ANTIFUNGAL, COSMETIC OR PHARMACEUTICAL COMPOSITION, AND FOOD SUPPLEMENT CONTAINING THE SAME
EP3160440B1 (en) Combination products and cosmetic compositions for controlling skin disorders and skin aging that affect keratinocytes and/or fibroblasts and the dermis
EP3134382B1 (en) Novel derivatives of benzyl benzoate
EP4037649A1 (en) Combination of ciclopiroxolamine and piroctone olamine for combating dandruff
FR3127133A1 (en) Extract of rapeseed meal, method of preparation and use in cosmetics, in particular as a propigmenting, slimming agent
FR2821271A1 (en) ORAL COMPOSITION FOR ADMINISTRATION AGAINST HAIR LOSS AND NAIL FRAGILITY
FR3125227A1 (en) New cosmetic compositions
KR100784088B1 (en) Composition for cosmetic pack with main component of Sangwhang-fungus powder and it's extraction
FR3098119A1 (en) PROCESS FOR OBTAINING A BOTANICAL THERMAL INFUSION
WO2009002208A1 (en) Microbiotic collagenase-based cosmetic agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08701386

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08701386

Country of ref document: EP

Kind code of ref document: A1